Upadacitinib for Prurigo Nodularis

Clinical trial NCT06773403 · TERMINATED

Trial details

NCT number: NCT06773403
Sponsor: Psoriasis Treatment Center of Central New Jersey
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Prurigo Nodularis

Start date: 2024-04-09
Primary completion: 2025-06-06
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.